Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
Katarina Tomović, Jelena Lazarević, Gordana Kocić, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 404-422
Open Access | Times Cited: 73

Showing 26-50 of 73 citing articles:

DPP-4 inhibition: А novel therapeutic approach to the treatment of pulmonary hypertension?
Marko Anderluh, Gordana Kocić, Katarina Tomović, et al.
Pharmacology & Therapeutics (2019) Vol. 201, pp. 1-7
Closed Access | Times Cited: 28
DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19—A Therapeutic Approach of Choice in Type 2 Diabetic Patients?
Andrija Šmelcerović, Gordana Kocić, Mihajlo Gajić, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 25
Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Primary care diabetes (2021) Vol. 16, Iss. 1, pp. 162-167
Open Access | Times Cited: 21
The Impact of Incretin-Based Medications on Lipid Metabolism
Habib Yaribeygi, Mina Maleki, Alexandra E. Butler, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 21
The Anti-Inflammatory Effect of Novel Antidiabetic Agents
Panagiotis Theofilis, Μarios Sagris, Evangelos Oikonomou, et al.
Life (2022) Vol. 12, Iss. 11, pp. 1829-1829
Open Access | Times Cited: 15
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease
Federico Bernardini, Annunziata Nusca, Federica Coletti, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1858-1858
Open Access | Times Cited: 8
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2
Zvonimir Bosnić, František Babič, Viera Anderková, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3695-3695
Open Access | Times Cited: 7
Benzimidazole-based dual dipeptidyl peptidase-4 and xanthine oxidase inhibitors
Katarina Tomović, Budimir S. Ilić, Žaklina Šmelcerović, et al.
Chemico-Biological Interactions (2019) Vol. 315, pp. 108873-108873
Open Access | Times Cited: 21
Structure–Activity Relationship Analysis of Cocrystallized Gliptin-like Pyrrolidine, Trifluorophenyl, and Pyrimidine-2,4-Dione Dipeptidyl Peptidase-4 Inhibitors
Katarina Tomović, Budimir S. Ilić, Andrija Šmelcerović
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 14, pp. 9639-9648
Closed Access | Times Cited: 16
Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes
Jianbin Guan, Haimiti Abudouaini, Kai‐Yuan Lin, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Pattern of Expression of Genes Involved in Systemic Inflammation and Glutathione Metabolism Reveals Exacerbation of COPD
Ingrid Oit-Wiscombe, László Virág, Kalle Kilk, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 953-953
Open Access | Times Cited: 2
UHT treatment and storage of liquid infant formula affects protein digestion and release of bioactive peptides
Yuhui Ye, Kasper Engholm‐Keller, Yajing Fang, et al.
Food & Function (2021) Vol. 13, Iss. 1, pp. 344-355
Closed Access | Times Cited: 15
An Overview, Advantages and Therapeutic Potential of Nonpeptide Positive Allosteric Modulators of Glucagon‐Like Peptide‐1 Receptor
Andrija Šmelcerović, Jelena Lazarević, Katarina Tomović, et al.
ChemMedChem (2019) Vol. 14, Iss. 5, pp. 514-521
Closed Access | Times Cited: 17
DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment
Momir Mikov, Nebojša Pavlović, Bojan Stanimirov, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2019) Vol. 45, Iss. 1, pp. 1-14
Closed Access | Times Cited: 15
Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats
Qian Zhang, Xinhua Xiao, Jia Zheng, et al.
Archives of Medical Science (2019) Vol. 17, Iss. 5, pp. 1378-1387
Open Access | Times Cited: 13
Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance
Nehal S. Wahba, Rasha H. Abdel‐Ghany, Salah A. Ghareib, et al.
European Journal of Pharmaceutical Sciences (2019) Vol. 144, pp. 105196-105196
Closed Access | Times Cited: 13
Efficacy and Safety of Sitagliptin in the Treatment of COVID-19
Ehab Mudher Mikhael, Siew Chin Ong, Siti Maisharah Sheikh Ghadzi
Journal of Pharmacy Practice (2022) Vol. 36, Iss. 4, pp. 980-987
Open Access | Times Cited: 8
Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies
Zhicheng Xu, Haidong Zhang, Chenghui Wu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study
Karolina Akinosoglou, Georgios Schinas, Evanthia Bletsa, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1416-1416
Open Access | Times Cited: 4
Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors
Kashif Rahim, Muhammad Shan, Ihtisham Ul Haq, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1897-1917
Open Access | Times Cited: 1
Vasorelaxant mechanisms of the antidiabetic anagliptin in rabbit aorta: roles of Kv channels and SERCA pump
Ryeon Heo, Minju Park, Seo‐Yeong Mun, et al.
Acta Diabetologica (2024)
Closed Access | Times Cited: 1
Linagliptin protects human chondrogenic ATDC5 cells against advanced glycation end products (AGEs)-induced apoptosis via a mitochondria-dependent pathway
Yanjie Zhang, Xiaohan Huang, Yanhao Yuan
Chemico-Biological Interactions (2019) Vol. 315, pp. 108901-108901
Closed Access | Times Cited: 10
Virtual screening strategy for anti-DPP-IV natural flavonoid derivatives based on machine learning
Gen Lu, Fei Pan, Xiaotong Li, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 13, pp. 6645-6659
Closed Access | Times Cited: 3
Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design
Sayyed Abbas Tabatabai, Hanieh Maleksabet, Elham Rezaee
Current Pharmaceutical Design (2022) Vol. 28, Iss. 45, pp. 3583-3591
Closed Access | Times Cited: 5
Purine adducts as a presumable missing link for aristolochic acid nephropathy‐related cellular energy crisis, potential anti‐fibrotic prevention and treatment
Gordana Kocić, Mihajlo Gajić, Katarina Tomović, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 22, pp. 4411-4427
Open Access | Times Cited: 7

Scroll to top